October 7, 2019
Novakar, Endo continue collaboration in $17.5 million product financing deal
Nevakar, ophthalmology specialist pharmaceutical company has entered into a $17.5 million product financing agreement with an affiliate of H.I.G. Capital Partners, L.P. for the continued development of five differentiated, sterile injectable products.